Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment

Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs

Scroll to Top